tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market
Advertisement

Zelira Therapeutics (ZLDAF) Income Statement

Compare
16 Followers

Zelira Therapeutics Income Statement

Last quarter (Q4 2025), Zelira Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Zelira Therapeutics's net income was AU$-1.22M. See Zelira Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 656.00AU$ 94.95KAU$ 301.12KAU$ 1.54MAU$ 663.32K
Gross Profit
AU$ -802.95KAU$ 10.28KAU$ -3.22MAU$ -5.72MAU$ -39.16K
Operating Expenses
AU$ 3.15MAU$ 5.95MAU$ 6.17MAU$ 7.70MAU$ 9.61M
Depreciation and Amortization
AU$ 147.05KAU$ 479.04KAU$ 545.22KAU$ 588.54KAU$ 474.25K
EBITDA
AU$ -4.17MAU$ -36.44MAU$ -6.79MAU$ -13.06MAU$ -9.41M
Operating Income
AU$ -3.95MAU$ -5.94MAU$ -7.41MAU$ -13.41MAU$ -9.65M
Other Income/Expenses
AU$ 102.52KAU$ -30.80MAU$ 1.29KAU$ -290.82KAU$ -275.31K
Pretax Income
AU$ -3.85MAU$ -36.74MAU$ -7.41MAU$ -13.71MAU$ -9.93M
Net Income
AU$ -3.63MAU$ -36.57MAU$ -5.57MAU$ -11.95MAU$ -8.55M
Per Share Metrics
Basic EPS
AU$ -0.32AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29
Diluted EPS
AU$ -0.32AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29
Weighted Average Shares Outstanding
11.48M 11.35M 10.07M 8.04M 6.63M
Weighted Average Shares Outstanding (Diluted)
11.48M 11.35M 10.07M 8.04M 6.63M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis